Jerald Radich, MD, hosts session on transplantation in CML at SOHO 2024
For more educational resources, become a SOHO member for free at soho.click/join.
Educational Resources
Meeting News
The Twelfth Annual Meeting of the Society of Hematologic Oncology
Video Interviews
Nitin Jain, MD, on Innovative Therapies in CLL
Hagop Kantarjian, MD, professor and chair in the Department of Leukemia at the University of Texas MD Anderson Cancer Center, and Nitin Jain,
Myeloproliferative Neoplasms
Primary Myelofibrosis
Fedratinib effective in patients with myelofibrosis previously treated with ruxolitinib
Results from the FREEDOM2 phase 3 trial supported the efficacy of fedratinib versus best available therapy (BAT) in patients with myelofibrosis previously treated
Lymphoma
Mantle Cell Lymphoma
Acalabrutinib granted Priority Review for patients with untreated MCL
The US Food and Drug Administration (FDA) has granted Priority Review status to the supplemental New Drug Application (sNDA) for acalabrutinib, a Bruton
Meeting News
Momelotinib has greater anemia-related benefits in myelofibrosis
Momelotinib was associated with greater anemia-related benefits in patients with myelofibrosis, according to an analysis presented at the 12th Annual Meeting of the
Meeting News
Meta-Analysis Investigates Daratumumab-Integrated Quadruple Therapy for Newly Diagnosed, Transplant-Eligible Patients With Multiple Myeloma
A meta-analysis suggests that incorporating daratumumab into standard triplet therapy for newly diagnosed, transplant-eligible patients with multiple myeloma (MM) is associated with higher
Cellular Therapy
Meeting News
High ‘Clinical Burden’ Despite Therapy Advances in Heavily Pretreated Patients With Relapsed Or Refractory Myeloma
Despite advancements in treatment options for relapsed or refractory multiple myeloma (MM), heavily pretreated patients continue to face significant clinical challenges, according to
Meeting News
Poster Winners Awarded at 12th Annual SOHO Meeting
Six poster winners were announced during Poster Session and Reception on Wednesday, September 4, at the Twelfth Annual Meeting of the Society of
Myelodysplastic Syndromes
NCCN Updates MDS Treatment Guidelines to Include Imetelstat Recommendations
The National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines for myelodysplastic neoplasms (MDS) to recommend imetelstat for treating symptomatic anemia
Multiple Myeloma
BVd Outperforms DVd in Phase III DREAMM 7 study
Belantamab mafodotin, bortezomib, and dexamethasone (BVd) treatment showed “significant benefit” in progression-free survival (PFS) when compared with daratumumab, bortezomib, and dexamethasone (DVd) in